Hypertension, Vol 6, 236-241, Copyright © 1984 by American Heart Association
M Handa, K Kondo, H Suzuki and T Saruta
Glucocorticoid hypertension was induced by oral administration of
dexamethasone (DX) in male Wistar rats. The mechanism of hypertension was
studied by observing the changes in plasma renin activity, urinary
excretion of prostaglandin E2 (PGE2), and the pressor response to
norepinephrine. Following administration of DX (0.1 mg/day), the blood
pressure began to rise within 3 days and reached a plateau on the 5th day
(from 108 +/- 2 to 162 +/- 7 mm Hg, mean +/- SE). On the other hand, urine
volume and urinary excretion of sodium were increased. In spite of the
marked natriuresis and diuresis, the administration of DX resulted in a
marked decrease in the urinary excretion of PGE2. This decrease in PGE2
excretion appeared before the blood pressure rose and continued throughout
the experiment. Plasma renin activity did not change. The pressor response
to norepinephrine was enhanced on the 2nd day of DX treatment, at which
time the blood pressure was not yet elevated, and it was further augumented
on the 6th day. In the DX- treated rats, the pressor response to
norepinephrine was not enhanced by administration of indomethacin, whereas
the pressor response was significantly potentiated by indomethacin in
control rats. These results suggest that DX-induced hypertension in rats is
associated with inhibition of prostaglandin synthesis leading to increased
sensitivity in the vascular response to norepinephrine.
ARTICLES
Dexamethasone hypertension in rats: role of prostaglandins and pressor sensitivity to norepinephrine
This article has been cited by other articles:
![]() |
M. Baum and O. W. Moe Glucocorticoid-Mediated Hypertension: Does the Vascular Smooth Muscle Hold All the Answers? J. Am. Soc. Nephrol., July 1, 2008; 19(7): 1251 - 1253. [Full Text] [PDF] |
||||
![]() |
D. O'Regan, C. J Kenyon, J. R Seckl, and M. C Holmes Prenatal dexamethasone 'programmes' hypotension, but stress-induced hypertension in adult offspring J. Endocrinol., February 1, 2008; 196(2): 343 - 352. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. M. Mitchell, A. M. Dorrance, and R. C. Webb GTP Cyclohydrolase 1 Downregulation Contributes to Glucocorticoid Hypertension in Rats Hypertension, March 1, 2003; 41(3): 669 - 674. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Sapolsky, L. M. Romero, and A. U. Munck How Do Glucocorticoids Influence Stress Responses? Integrating Permissive, Suppressive, Stimulatory, and Preparative Actions Endocr. Rev., February 1, 2000; 21(1): 55 - 89. [Abstract] [Full Text] |
||||
![]() |
H. Hatakeyama, S. Inaba, and I. Miyamori 11ß-Hydroxysteroid Dehydrogenase in Cultured Human Vascular Cells : Possible Role in the Development of Hypertension Hypertension, May 1, 1999; 33(5): 1179 - 1184. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E Ullian The role of corticosteroids in the regulation of vascular tone Cardiovasc Res, January 1, 1999; 41(1): 55 - 64. [Full Text] [PDF] |
||||
![]() |
M. E. Ullian, D. J. Hazen-Martin, L. G. Walsh, R. K. Davda, and B. M. Egan Carbenoxolone Damages Endothelium and Enhances Vasoconstrictor Action in Aortic Rings Hypertension, June 1, 1996; 27(6): 1346 - 1352. [Abstract] [Full Text] |
||||
![]() |
M. E. Ullian and L. G. Walsh Corticosterone Metabolism and Effects on Angiotensin II Receptors in Vascular Smooth Muscle Circ. Res., October 1, 1995; 77(4): 702 - 709. [Abstract] [Full Text] |
||||
![]() |
S. Murasawa, H. Matsubara, K. Kizima, K. Maruyama, Y. Mori, and M. Inada Glucocorticoids Regulate V1a Vasopressin Receptor Expression by Increasing mRNA Stability in Vascular Smooth Muscle Cells Hypertension, October 1, 1995; 26(4): 665 - 669. [Abstract] [Full Text] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1984 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |